Literature DB >> 23127749

Biometric and molecular characterization of clinically diagnosed posterior microphthalmos.

Sawsan R Nowilaty1, Arif O Khan, Mohammed A Aldahmesh, Khalid F Tabbara, Abdullah Al-Amri, Fowzan S Alkuraya.   

Abstract

PURPOSE: To biometrically and molecularly characterize clinically diagnosed posterior microphthalmos.
DESIGN: Prospective case series.
METHODS: Twenty-five affected patients from 13 families diagnosed by ophthalmologists experienced with the condition at the King Khaled Eye Specialist Hospital were studied. All participants underwent axial length measurement, keratometry, corneal pachymetry, and candidate gene analysis (MFRP, PRSS56). Main outcome measures were the results of ocular biometry and gene analysis.
RESULTS: All patients (2-47 years of age) had high hyperopia, normal-appearing anterior segments, posterior chamber foreshortening, and characteristic papillomacular folds/wrinkles. For the right eye, mean cycloplegic refraction was +15.09 diopters (D) (range 9.88-18.75). Axial length (mean 16.25 mm [range 14.88-19.88]) had strong inverse correlation (Pearson coefficient -0.88, P < .0001) with corneal power (mean 48.89 D [range 41.91-52.25]) and a positive correlation with corneal diameter (Pearson 0.64, P = .001). Corneal thickness and anterior chamber dimensions were within normal ranges. Left eye data were similar. Nineteen Saudi patients (8/13 families) harbored 4 different homozygous PRSS56 mutations, 1 Indian and 1 Saudi patient harbored 2 different homozygous MFRP mutations, and 4 Saudi patients (3/13 families) had no detectable mutation in either gene. Patients with MFRP mutations were not clinically different from patients with PRSS56 mutations or no identified mutation. Truncating PRSS56 mutations were associated with shorter axial lengths (mean 15.72 mm) than missense PRSS56 mutations (mean 16.37 mm) or no identified mutation (mean 17.57 mm).
CONCLUSIONS: These data define posterior microphthalmos biometrically and reveal that corneal steepening proportional to the degree of axial foreshortening is part of the phenotype. Corneal diameter decreases with decreasing axial length, suggesting posterior microphthalmos and nanophthalmos represent a spectrum of high hyperopia rather than distinct phenotypes. In the Saudi population PRSS56 mutations are the major cause, and in our cohort truncating mutations were associated with a more severe phenotype.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23127749     DOI: 10.1016/j.ajo.2012.08.016

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  20 in total

1.  Clinical utility gene card for: Non-Syndromic Microphthalmia Including Next-Generation Sequencing-Based Approaches.

Authors:  Rose Richardson; Jane Sowden; Christina Gerth-Kahlert; Anthony T Moore; Mariya Moosajee
Journal:  Eur J Hum Genet       Date:  2017-01-18       Impact factor: 4.246

2.  Clinical features of posterior microphthalmic and nanophthalmic eyes.

Authors:  Jing-Jing Liu; Yi-Ye Chen; Xiang Zhang; Pei-Quan Zhao
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

3.  Nanophthalmos and hemiretinal vein occlusion: A case report.

Authors:  Ahmad A Albar; Sawsan R Nowilaty; Nicola G Ghazi
Journal:  Saudi J Ophthalmol       Date:  2014-11-27

4.  Mutations in LRPAP1 are associated with severe myopia in humans.

Authors:  Mohammed A Aldahmesh; Arif O Khan; Hisham Alkuraya; Nouran Adly; Shamsa Anazi; Ahmed A Al-Saleh; Jawahir Y Mohamed; Hadia Hijazi; Sarita Prabakaran; Marlene Tacke; Abdullah Al-Khrashi; Mais Hashem; Thomas Reinheckel; Abdullah Assiri; Fowzan S Alkuraya
Journal:  Am J Hum Genet       Date:  2013-07-03       Impact factor: 11.025

5.  The genetic and clinical landscape of nanophthalmos and posterior microphthalmos in an Australian cohort.

Authors:  Owen M Siggs; Mona S Awadalla; Emmanuelle Souzeau; Sandra E Staffieri; Lisa S Kearns; Kate Laurie; Abraham Kuot; Ayub Qassim; Thomas L Edwards; Michael A Coote; Erica Mancel; Mark J Walland; Joanne Dondey; Anna Galanopoulous; Robert J Casson; Richard A Mills; Daniel G MacArthur; Jonathan B Ruddle; Kathryn P Burdon; Jamie E Craig
Journal:  Clin Genet       Date:  2020-03-05       Impact factor: 4.438

6.  High-hyperopia database, part I: clinical characterisation including morphometric (biometric) differentiation of posterior microphthalmos from nanophthalmos.

Authors:  N Relhan; S Jalali; N Pehre; H L Rao; U Manusani; L Bodduluri
Journal:  Eye (Lond)       Date:  2015-10-23       Impact factor: 3.775

7.  Posterior microphthalmos and papillomacular fold-associated cystic changes misdiagnosed as cystoid macular edema following cataract extraction.

Authors:  Ahmad A Albar; Sawsan R Nowilaty; Nicola G Ghazi
Journal:  Clin Ophthalmol       Date:  2015-01-07

8.  Pseudodominant Nanophthalmos in a Roma Family Caused by a Novel PRSS56 Variant.

Authors:  Lubica Dudakova; Pavlina Skalicka; Olga Ulmanová; Martin Hlozanek; Viktor Stranecky; Frantisek Malinka; Andrea L Vincent; Petra Liskova
Journal:  J Ophthalmol       Date:  2020-05-10       Impact factor: 1.909

9.  Posterior Microphthalmia, Peripheral Pigmentary Retinal Changes, Yellow Lesions, and Cleft Lip: A Case Report and Literature Review.

Authors:  Nasser G Alsaedi; Khalid Alrubaie
Journal:  Case Rep Ophthalmol Med       Date:  2019-05-19

Review 10.  Nanophthalmos: A Review of the Clinical Spectrum and Genetics.

Authors:  Pedro C Carricondo; Thais Andrade; Lev Prasov; Bernadete M Ayres; Sayoko E Moroi
Journal:  J Ophthalmol       Date:  2018-05-09       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.